Myopathy secondary to simvastatin in a type 2 diabetic patient.
The most important but rare adverse effect of simvastatin is myopathy. In megatrials with simvastatin, the overall incidence of myopathy is 0.025%. We present a case of myopathy presenting as proximal muscle weakness in both upper limbs secondary to simvastatin which reversed spontaneously after cessation of the drug.
Udawat
H
H
JLN Medical College and AG Hospitals, Ajmer.
Goyal
R K
RK
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced* / Q000503:physiopathology; D019821:Simvastatin / Q000009:adverse effects*
D000924:Anticholesteremic Agents; D019821:Simvastatin